Literature DB >> 23702825

Toxicity assessment of manganese oxide micro and nanoparticles in Wistar rats after 28 days of repeated oral exposure.

Shailendra Pratap Singh1, Monika Kumari, Srinivas I Kumari, Mohammed F Rahman, M Mahboob, Paramjit Grover.   

Abstract

In the near future, nanotechnology is envisaged for large-scale use. Hence health and safety issues of nanoparticles (NPs) should be promptly addressed. Twenty-eight-day oral toxicity, genotoxicity, biochemical alterations, histopathological changes and tissue distribution of nano and microparticles (MPs) of manganese oxide (MnO2 ) in Wistar rats was studied. Genotoxicity was assessed using comet, micronucleus and chromosomal aberration assays. The results demonstrated a significant increase in DNA damage in leukocytes, micronuclei and chromosomal aberrations in bone marrow cells after exposure of MnO2 -NPs at 1000, 300 mg kg(-1) bw per day and MnO2 -MPs at the dose of 1000 mg kg(-1) bw per day. Our findings showed acetylcholinestrase inhibition at 1000 as well as at 300 mg kg(-1) bw per day in blood and with all the doses in the brain indicating the toxicity of MnO2 -NPs. Further, the doses significantly inhibited different ATPases in the brain P2 fraction. Significant changes were observed in aspartate aminotransferase (AST), alanine aminotransferase (ALT) and lactate dehydrogenase (LDH) in the liver, kidney and serum in a dose-dependent manner. MnO2 -MPs at 1000 mg kg(-1) bw per day were found to induce significant alterations in biochemical enzymes. A significant distribution was found in all the tissues in a dose-dependent manner. MnO2 -NPs showed a much higher absorptivity and tissue distribution as compared with MnO2 -MPs. A large fraction of MnO2 -NPs and MnO2 -MPs was cleared by urine and feces. Histopathological analysis revealed that MnO2 -NPs caused alterations in liver, spleen, kidney and brain. The MnO2 -NPs induced toxicity at lower doses compared with MnO2 -MPs. Further, this study did not display gender differences after exposure to MnO2 -NPs and MnO2 -MPs. Therefore, the results suggested that prolonged exposure to MnO2 has the potential to cause genetic damage, biochemical alterations and histological changes.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  MnO2-MPs; MnO2-NPs; Wistar rats; biochemical parameters; biodistribution; genotoxicity

Mesh:

Substances:

Year:  2013        PMID: 23702825     DOI: 10.1002/jat.2887

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  13 in total

Review 1.  Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications.

Authors:  Raziye Mohammadpour; Marina A Dobrovolskaia; Darwin L Cheney; Khaled F Greish; Hamidreza Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2019-07-08       Impact factor: 15.470

Review 2.  Biological monitoring of workers exposed to engineered nanomaterials.

Authors:  P Schulte; V Leso; M Niang; I Iavicoli
Journal:  Toxicol Lett       Date:  2018-06-18       Impact factor: 4.372

3.  Genotoxic effects of chromium oxide nanoparticles and microparticles in Wistar rats after 28 days of repeated oral exposure.

Authors:  Shailendra Pratap Singh; Srinivas Chinde; Sarika Srinivas Kalyan Kamal; M F Rahman; M Mahboob; Paramjit Grover
Journal:  Environ Sci Pollut Res Int       Date:  2015-10-27       Impact factor: 4.223

Review 4.  Plant-based metallic nanoparticles as potential theranostics agents: bioinspired tool for imaging and treatment.

Authors:  Adila Nazli; Muhammad Waleed Baig; Muhammad Zia; Muhammad Ali; Zabta Khan Shinwari; Ihsan Ul Haq
Journal:  IET Nanobiotechnol       Date:  2018-10       Impact factor: 1.847

Review 5.  Applications and Biological Activity of Nanoparticles of Manganese and Manganese Oxides in In Vitro and In Vivo Models.

Authors:  Zuzanna Sobańska; Joanna Roszak; Kornelia Kowalczyk; Maciej Stępnik
Journal:  Nanomaterials (Basel)       Date:  2021-04-22       Impact factor: 5.076

Review 6.  Some inferences from in vivo experiments with metal and metal oxide nanoparticles: the pulmonary phagocytosis response, subchronic systemic toxicity and genotoxicity, regulatory proposals, searching for bioprotectors (a self-overview).

Authors:  Boris A Katsnelson; Larisa I Privalova; Marina P Sutunkova; Vladimir B Gurvich; Nadezhda V Loginova; Ilzira A Minigalieva; Ekaterina P Kireyeva; Vladimir Y Shur; Ekaterina V Shishkina; Ya B Beikin; Oleg H Makeyev; Irene E Valamina
Journal:  Int J Nanomedicine       Date:  2015-04-16

7.  Attenuation of Combined Nickel(II) Oxide and Manganese(II, III) Oxide Nanoparticles' Adverse Effects with a Complex of Bioprotectors.

Authors:  Ilzira A Minigalieva; Boris A Katsnelson; Larisa I Privalova; Marina P Sutunkova; Vladimir B Gurvich; Vladimir Y Shur; Ekaterina V Shishkina; Irene E Valamina; Oleg H Makeyev; Vladimir G Panov; Anatoly N Varaksin; Ekaterina V Grigoryeva; Ekaterina Y Meshtcheryakova
Journal:  Int J Mol Sci       Date:  2015-09-17       Impact factor: 5.923

8.  The most important inferences from the Ekaterinburg nanotoxicology team's animal experiments assessing adverse health effects of metallic and metal oxide nanoparticles.

Authors:  Marina P Sutunkova; Larisa I Privalova; Ilzira A Minigalieva; Vladimir B Gurvich; Vladimir G Panov; Boris A Katsnelson
Journal:  Toxicol Rep       Date:  2018-03-08

9.  MnO nanoparticles with potential application in magnetic resonance imaging and drug delivery for myocardial infarction.

Authors:  Yuanyuan Zheng; Hong Zhang; Yuping Hu; Lu Bai; Jingyi Xue
Journal:  Int J Nanomedicine       Date:  2018-10-08

10.  Effects of SiO₂, ZrO₂, and BaSO₄ nanomaterials with or without surface functionalization upon 28-day oral exposure to rats.

Authors:  Roland Buesen; Robert Landsiedel; Ursula G Sauer; Wendel Wohlleben; Sibylle Groeters; Volker Strauss; Hennicke Kamp; Bennard van Ravenzwaay
Journal:  Arch Toxicol       Date:  2014-08-28       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.